(Reuters) -The U.S. Food and Drug Administration said on Friday it has cleared Fujirebio Diagnostics’ blood test to diagnose Alzheimer’s disease, making it the first of its kind to detect the condition. Blood testing is initially likely to be used to rule out Alzheimer’s, with positive results …
